Indian study adds to uncertainty about the value of COVID-19 convalescent plasma Sep. 16, 2020 By Michael Fitzhugh No Comments A new randomized controlled trial (RCT) of COVID-19 convalescent plasma (CCP) treatment for moderately ill COVID-19 patients run at 39 Indian hospitals found no association between CCP therapy and reduced mortality or progression to severe disease.Read More